SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
---------------
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarter ended September 30, 1997
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
For the transition period from __________________ to ________________
Commission File No. 1-13392
US DIAGNOSTIC INC.
(Exact name of registrant specified in its charter)
<TABLE>
<CAPTION>
DELAWARE 11-3164389
- -------------------------------------------------------------- ------------------------------------
<S> <C>
(State or Other Jurisdiction of Incorporation or Organization) (IRS Employer Identification Number)
</TABLE>
777 S. Flagler Drive
Suite 1201 East
West Palm Beach, Florida 33401
(Address of Principal Executive Offices)
(561) 832-0006
(Issuer's Telephone Number, Including Area Code)
(Not Applicable)
(Former Name, Former Address and Former Fiscal Year,
If Changed Since Last Report)
Indicate by check mark whether the issuer (1) filed all
reports required to be filed by section 13 or 15 (d) of the Securities
Exchange Act of 1934 during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
Yes X No______
State the number of shares outstanding of each of the issuer's
classes of common equity, as of the latest practicable date.
CLASS OUTSTANDING AT NOVEMBER 11, 1997:
----- ---------------------------------
Common Stock, $ .01 par value 22,810,498 shares
<PAGE>
EXPLANATORY NOTE
This Form 10-Q/A constitutes Amendment No. 1 to the Company's Quarterly Report
on Form 10-Q for the quarterly period ended September 30, 1997, and is being
filed solely for the purpose of amending Item 6. - Exhibits and Reports on Form
8-K. The Company inadvertently omitted reference in its Form 10-Q to the reports
on Form 8-K that were filed by the Company during the quarter ended September
30, 1997.
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
<TABLE>
<CAPTION>
EXHIBIT INDEX
<S> <C>
4.1 - Form of Amended and Restated 6 1/2% Convertible Negotiable Note Due June 30, 2001.
10.1 - Employment Agreement dated October 20, 1997 between the Company and Leon Maraist.
10.2 Settlement Agreement and General Release dated September 30, 1997 between the Company and
Jeffrey Goffman.
10.3 - Form of Loan and Security Agreement among Medical Diagnostics Inc., the Company and DVI Financial
Services Inc. dated September 29, 1997.
10.4 - Form of Secured Promissory Note due October 1, 2002 by Medical Diagnostics Inc. to DVI Financial Services Inc.
10.5 - Unconditional Continuing Guaranty dated September 29, 1997 for the benefit of DVI Financial Services Inc. by
the Company
10.6 - Stock Pledge Agreement dated September 29, 1997 between the Company, DVI Financial Services Inc. and
DVI Business Credit Corporation.
10.7 - Common Stock Purchase Warrant dated September 29, 1997 of the Company issued to DVI Financial
Services Inc.
10.8 - Common Stock Purchase Warrant dated September 29, 1997 of the Company issued to DVI Financial
Services Inc.
10.9 - Letter of Agreement dated September 29, 1997 between the Company and
DVI Business Credit Corporation confirming amendment of Loan and
Security Agreement dated as of February 25, 1997.
11 - Earnings Per Share Calculation.
27 - Financial Data Schedule.
(b) A Form 8-K was filed July 1, 1997, disclosing under Item 2 of Form
8-K that the Company had completed its acquisition of Medical Imaging
Centers of America, Inc. ("MICA") on November 12, 1996. Certain
financial statements of MICA and pro forma financial statements
reflecting the acquisition of MICA were filed with the Form 8-K under
Item 7.
A Form 8-K/A was filed on July 21, 1997, amending the Form 8-K
filed on July 1, 1997, for the purposes of filing certain additional
financial statements of MICA under Item 7.
A Form 8-K was filed on August 5, 1997, disclosing under Item 5
that the Company had reached a settlement in principle, subject to
certain terms and conditions including court approval and notice to the
class members, of all of the shareholder class actions brought against
the Company in January 1997. A Memorandum of Understanding relating to
the settlement and a press release disclosing the settlement were filed
as exhibits with the Form 8-K under Item 7.
</TABLE>
2
<PAGE>
<TABLE>
<CAPTION>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
US DIAGNOSTIC INC.
<S> <C>
Dated: December 12, 1997 By: /s/ Wayne Moor
-------------------------------
Wayne Moor
Vice President and Chief Financial Officer
(Duly Authorized Officer and Principal Financial Officer)
</TABLE>
3
